Enrolling by Invitation
DMSO Dual-Route Therapy for Refractory Tinnitus in Long-COVID and Post-COVID-19 Vaccine Injury
NCT07567274
- Conditions
- COVID-19, Chronic Disease, Coronaviridae Infections, +23 more
- Locations
-
- Nationwide Telemedicine Study (Leading Edge Clinic) Ithaca, New York, United States